Prevail Innovative Wealth Advisors LLC Purchases 4,166 Shares of Chemed Co. (NYSE:CHE)

Prevail Innovative Wealth Advisors LLC boosted its position in Chemed Co. (NYSE:CHEFree Report) by 75.0% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 9,723 shares of the company’s stock after purchasing an additional 4,166 shares during the period. Chemed comprises 1.5% of Prevail Innovative Wealth Advisors LLC’s investment portfolio, making the stock its 16th biggest position. Prevail Innovative Wealth Advisors LLC owned approximately 0.06% of Chemed worth $5,151,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of the company. UMB Bank n.a. increased its position in shares of Chemed by 300.0% during the fourth quarter. UMB Bank n.a. now owns 52 shares of the company’s stock valued at $28,000 after acquiring an additional 39 shares during the last quarter. Atala Financial Inc bought a new position in Chemed during the fourth quarter valued at $29,000. CBIZ Investment Advisory Services LLC lifted its position in shares of Chemed by 64.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company’s stock worth $30,000 after acquiring an additional 22 shares in the last quarter. Trust Co. of Vermont bought a new position in shares of Chemed in the fourth quarter worth $34,000. Finally, Tortoise Investment Management LLC grew its position in shares of Chemed by 77.3% in the fourth quarter. Tortoise Investment Management LLC now owns 78 shares of the company’s stock valued at $41,000 after purchasing an additional 34 shares in the last quarter. Institutional investors own 95.85% of the company’s stock.

Insider Activity

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction dated Thursday, March 6th. The stock was sold at an average price of $593.67, for a total transaction of $1,187,340.00. Following the sale, the chief executive officer now owns 102,679 shares in the company, valued at $60,957,441.93. This trade represents a 1.91 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, VP Brian C. Judkins acquired 145 shares of Chemed stock in a transaction dated Monday, December 30th. The shares were purchased at an average price of $519.50 per share, for a total transaction of $75,327.50. Following the completion of the transaction, the vice president now directly owns 1,678 shares in the company, valued at approximately $871,721. The trade was a 9.46 % increase in their position. The disclosure for this purchase can be found here. Corporate insiders own 3.32% of the company’s stock.

Analysts Set New Price Targets

CHE has been the topic of a number of recent research reports. StockNews.com raised Chemed from a “hold” rating to a “buy” rating in a report on Friday, March 7th. Royal Bank of Canada increased their price target on shares of Chemed from $633.00 to $667.00 and gave the stock an “outperform” rating in a report on Friday, March 14th.

Get Our Latest Research Report on CHE

Chemed Trading Down 1.0 %

Shares of NYSE CHE opened at $605.94 on Friday. The business has a 50-day moving average of $574.16 and a 200-day moving average of $566.66. The firm has a market capitalization of $8.87 billion, a price-to-earnings ratio of 30.62, a PEG ratio of 2.15 and a beta of 0.43. Chemed Co. has a 12 month low of $512.12 and a 12 month high of $642.68.

Chemed Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 0.33%. The ex-dividend date was Monday, February 24th. Chemed’s dividend payout ratio (DPR) is currently 10.05%.

About Chemed

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Recommended Stories

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHEFree Report).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.